VIATRIS INC. for VIATRIS INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
President's Emergency Plan for AIDS Relief funding, Global Fund funding, FY 2015 Budget, FY2015 House and Senate Appropriations, Generic Drug User Fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Trade (domestic/foreign) TRD
General trade issues, Trans Pacific Partnership
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Reform, Tax Extenders, Administrations Tax Reform and 2015 Budget Proposals; Proposals to reform domestic and international tax structures, Tax Treatment of Patent Infringement Litigation costs
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Health Issues HCR
FDA proposed rule, Supplemental Applications Proposing Labeling Changes For Approved Drugs And Biological Products, Docket Number FDA-2013-N-0500, provisions relating to generic drug labeling changes; Proposed FDA rule, "Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products," RIN: 0910-AG18, provisions relating to the use of electronic package inserts for human pharmaceuticals and biologics; Implementation of Biosimilars in the Affordable Care Act (ACA), Biosimilar Naming, Implementation of FDASIA and Generic Drug User Fee Act; H.R. 4437, The Generic Drug Pricing Transparency Act, Generic drug pricing issues, Medicare Part D program and Generic Drugs; H.R. 5657, the Fair Access for Safe and Timely Generics Act of 2014 (FAST Generics Act) PEPFAR program supply chain management
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.